Screener
PJP vs BMED
Invesco Pharmaceuticals ETF vs iShares Health Innovation Active ETF
Key differences
- PJP is significantly larger than BMED — larger funds tend to be more liquid and less likely to close.
- PJP follows a index tracking strategy; BMED uses active selection.
- Over the last 3 years, PJP has delivered higher annualized returns.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PJP | BMED | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.55% |
| Fund size (AUM) | $334M | $10M |
| Since | 2005 | 2020 |
| Dividend yield | 1.01% | 0.00% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | active selection |
| CAGR 1Y | +38.9% | +18.0% |
| CAGR 3Y | +14.0% | +4.9% |
| CAGR 5Y | +7.4% | +0.1% |
| Sharpe 3Y | 0.69 | 0.16 |
| Volatility 1Y | 16.19% | 14.94% |
| Max drawdown | -33.95% | -36.44% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and BMED
Explore further